Trident Brands (TDNT) 10-K 28 Feb 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Thousands	12 Months Ended
	Nov. 30, 2016	Feb. 28, 2017	May 31, 2016
Document And Entity Information [Abstract]
Entity Registrant Name	Trident Brands Inc
Entity Central Index Key	1,421,907
Trading Symbol	tdnt
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Current Fiscal Year End Date	--11-30
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding		31,000,000
Entity Public Float			$ 0
Document Type	10-K
Document Period End Date	Nov. 30, 2016
Amendment Flag	false
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Nov. 30, 2016	Nov. 30, 2015
Current Assets
Cash	$ 1,527,624	$ 187,886
Accounts Receivable	53,053
Inventory	231,221	145,480
Prepaid	67,332	55,887
Total Current Assets	1,879,230	389,253
Intangible Assets - Licenses, net	2,425,000
TOTAL ASSETS	4,304,230	389,253
Current Liabilities
Accounts Payable	106,612	184,680
Accrued Liability	431,178	181,024
Loan Payable - Related Party, net of discount $8,812 and $0, respectively	191,188	180,000
Loan Payable - Third Party, net of discount $18,135 and $0, respectively		300,000
Convertible Debt, net of discount $0 and $147,230, respectively		2,152,770
Total Current Liabilities	728,978	2,998,474
Convertible Debt, net of discount $1,285,836	5,114,164
Total Liabilities	5,843,142	2,998,474
Stockholders' Deficit
Common stock, $0.001 par value, 300,000,000 shares authorized; 31,000,000 shares issued and outstanding as of November 30, 2016 and 28,000,000 as of November 30, 2015, respectively	31,000	28,000
Additional paid-in capital	5,431,976	1,177,540
Non-Controlling Interest in Subsidiary	(65,786)	(14,643)
Accumulated Deficit	(6,936,102)	(3,800,118)
Total Stockholders' Deficit	(1,538,912)	(2,609,221)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT	$ 4,304,230	$ 389,253

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Nov. 30, 2016	Nov. 30, 2015
Statement of Financial Position [Abstract]
Discount on Loan Payable - Related Party	$ 8,812	$ 0
Discount on Loan Payable - Third Party	18,135	0
Discount on Convertible Debt current	0	$ 147,230
Discount on Convertible Debt noncurrent	$ 1,285,836
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	31,000,000	28,000,000
Common stock, shares outstanding	31,000,000	28,000,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Income Statement [Abstract]
Revenues	$ 168,042	$ 16,569
Cost of Sales	97,738	9,951
Gross Profit	70,304	6,618
General & Administrative Expenses	(2,681,358)	(2,511,893)
Loss from Operations	(2,611,054)	(2,505,275)
Other Income (Expenses)
Interest Expense	(576,073)	(664,549)
Total Other Income (Expenses)	(576,073)	(664,549)
Net Loss	(3,187,127)	(3,169,824)
Net loss attributable to Trident	(3,135,984)	(3,155,181)
Net loss attributable to Non-Controlling Interests	$ (51,143)	$ (14,643)
Loss per share - Basic and diluted (in dollars per share)	$ (0.10)	$ (0.11)
Weighted average number of common shares outstanding - Basic and diluted (in shares)	30,696,721	28,000,000

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Non-Conrolling Interest	Total
Balance at Nov. 30, 2014	$ 28,000	$ 47,000	$ (644,937)		$ (569,937)
Balance (in shares) at Nov. 30, 2014	28,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beneficial Conversion Feature on Convertible Debt		647,887			647,887
Stock Options Expenses		482,653			482,653
Net Loss			(3,155,181)	(14,643)	(3,169,824)
Balance at Nov. 30, 2015	$ 28,000	1,177,540	(3,800,118)	(14,643)	$ (2,609,221)
Balance (in shares) at Nov. 30, 2015	28,000,000				28,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beneficial Conversion Feature on Convertible Debt		1,366,667			$ 1,366,667
Oceans Omega License	$ 3,000	2,697,000			2,700,000
Oceans Omega License (in shares)	3,000,000
Stock Options Expenses		111,994			111,994
Warrant Expenses		78,775			78,775
Net Loss			(3,135,984)	(51,143)	(3,187,127)
Balance at Nov. 30, 2016	$ 31,000	$ 5,431,976	$ (6,936,102)	$ (65,786)	$ (1,538,912)
Balance (in shares) at Nov. 30, 2016	31,000,000				31,000,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,187,127)	$ (3,169,824)
Adjustments to reconcile net loss to net cash used in operating activities:
Debt issuance cost		34,250
Amortization of debt discount	298,025	500,657
Amortization of license	275,000
Stock options expenses	111,994	482,653
Changes in operating assets and liabilities:
Accounts Receivable	(53,053)
Prepaid expenses	(11,446)	(54,838)
Inventory	(85,741)	(145,480)
Accounts payable and accrued liabilities	172,086	148,186
Cash used in operating activities	(2,480,262)	(2,204,396)
CASH FLOWS FROM FINANCING ACTIVITIES
Principal payments on loan payable - related party	(180,000)	(140,070)
Proceeds on loan payable - related party	200,000	255,000
Principal payments on loan payable - third party	(550,000)	(123,000)
Proceeds on loan payable - third party	250,000	100,000
Proceeds on convertible debt	4,100,000	2,300,000
Cash provided by financing activities	3,820,000	2,391,930
Net change in cash	1,339,738	187,534
Cash at beginning of period	187,886	352
Cash at end of period	1,527,624	187,886
NON-CASH TRANSACTIONS
Beneficial conversion features	1,366,667	647,887
Common stock issued for asset acquisition	2,700,000
Relative fair value of warrants recorded as debt discount	78,775
Cash paid for:
Income taxes
Interest	$ 86,611	$ 34,250

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	12 Months Ended
	Nov. 30, 2016
Organization And Description Of Business [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS Trident Brands Incorporated (f/k/a Sandfield Ventures Corp.) (“we”, “our”, “the Company”) was incorporated under the laws of the State of Nevada on November 5, 2007. The Company was formed to engage in the acquisition, exploration and development of natural resource properties. The Company is now focused on the development of high growth branded and private label consumer products and ingredients within the nutritional supplement, life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super-8 filing at the end of August, 2014. Activities to date have focused on capital formation, organizational development and execution of its branded and private label consumer products and ingredients business plan.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Nov. 30, 2016
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Accounting The Company’s financial statements are prepared using the accrual method of accounting. The Company has elected a November 30, year-end. Use of Estimates and Assumptions The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. In accordance with ASC No. 250 all adjustments are normal and recurring. Principal of Consolidation The Company consolidated financial statements as of November 30, 2016 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd, Sports Nutrition Products Inc., Brain Armor Inc. and Trident Brands International Ltd. Basic Earnings (loss) Per Share ASC No. 260, “Earnings Per Share”, specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. The Company has adopted the provisions of ASC No. 260. Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary. Management has determined that a reserve for uncollectible amounts was not required in the periods presented. Inventory Inventories are stated at the lower of cost or market. Cost is principally determined using the first-in, first-out (FIFO) method. Long-Lived Assets We review our long-lived assets, to include intangible assets subject to amortization, for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as "the asset") may not be recoverable. Such circumstances include, but are not limited to: · a significant decrease in the market price of the asset; · a significant change in the extent or manner in which the asset is being used; · a significant change in the business climate that could affect the value of the asset; · a current period loss combined with projection of continuing loss associated with use of the asset; and · a current expectation that, more likely than not, the asset will be sold or otherwise disposed of before the end of its previously estimated useful life. We continually evaluate whether such events and circumstances have occurred. When such events or circumstances exist, the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset. To date, no such impairment has occurred. To the extent such events or circumstances occur that could affect the recoverability of our long-lived assets, we may incur charges for impairment in the future. Impairment of Long-Lived Assets The Company evaluates, on a periodic basis, long-lived assets to be held and used for impairment in accordance with the reporting requirements of ASC 360-10. The evaluation is based on certain impairment indicators, such as the nature of the assets, the future economic benefit of the assets, any historical or future profitability measurements, as well as other external market conditions or factors that may be present. If these impairment indicators are present or other factors exist that indicate that the carrying amount of the asset may not be recoverable, then an estimate of the undiscounted value of expected future operating cash flows is used to determine whether the asset is recoverable and the amount of any impairment is measured as the difference between the carrying amount of the asset and its estimated fair value. The fair value is estimated using valuation techniques such as market prices for similar assets or discounted future operating cash flows. Beneficial Conversion Features The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion. Fair Value of Financial Instruments The company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars. Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. Revenue The Company maintains a portfolio of branded and private label consumer products including nutritional products and supplements under the Everlast® and Brain Armor® brands, and functional food ingredients under the Oceans Omega brand. Revenue for 2016 was $168,042. Two customers accounted for 48.9% and 27.2% of total revenue. With the delisting of one of our products, we adjusted fourth quarter revenues downward by $94,308 based on a calculation of the estimated product to be returned by one of our customers in the second quarter of 2017. The Company records revenue based on the following four criteria: collection probability is reasonably assured, product is shipped or delivery is complete (depending on the terms), persuasive evidence of an arrangement with the customer exists and the price to the customer can be determined. Cost of Sales Cost of sales includes the direct purchase cost of the product based on the FIFO method. Cost of sales for 2016 was $97,738. Cost of sales was adjusted downward by $49,040 in the fourth quarter for the estimated product to be returned as noted above under Revenue. Employee Stock-Based Compensation The company accounts for employee stock-based compensation in accordance with ASC-718, “Compensation-Stock Compensation”. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Non-Employee Stock-Based Compensation: The Company accounts for non-employee stock-based compensation in accordance with the provision of ASC 505-50, “Equity Based Payments to Non-Employees” (“ASC 505-50”), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest. Income Taxes Income taxes are provided in accordance with ASC No. 740, Accounting for Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion of all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Related Parties A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party. Recent Accounting Pronouncements The Company has evaluated all the recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that none of them will have a material effect on the Company’s financial statements

LIQUIDITY

LIQUIDITY	12 Months Ended
	Nov. 30, 2016
Liquidity [Abstract]
LIQUIDITY	NOTE 3. LIQUIDITY On September 26, 2016, the Company completed a long term financing with a non-US institutional investor, receiving proceeds of $4,100.000 through the issuance of a secured convertible promissory note. The investor has agreed to make additional investments at the Company’s request of up to $5,900,000 ($10,000,000 in the aggregate). On November 30, 2016 the Company had $1,527,624 in cash and has access to $5,900,000 available from the investor. The Company feels this represents substantial liquid resources (cash & available financing), sufficient to meet the Company’s obligations for the next twelve months, and as a result, the going concern disclosure is not warranted for the year ended November 30, 2016.

WARRANTS AND OPTIONS

WARRANTS AND OPTIONS	12 Months Ended
	Nov. 30, 2016
Warrants And Options [Abstract]
WARRANTS AND OPTIONS	NOTE 4. WARRANTS AND OPTIONS On May 5, 2014, Trident granted an aggregate of 2,875,000 stock options to directors, officers, employees and consultants of the Company pursuant to Trident’s 2013 Stock Plan. The stock options are exercisable for five years from the date of grant at exercise prices of $0.75 per share for shares vesting 12 months from the date of issuance, $1.00 per share for shares vesting 24 months from the date of issuance and $1.50 for shares vesting 36 months from the date of issuance. Of the 2,875,000 stock options granted, Trident granted 1,125,000 stock options to its president, Michael Browne; 300,000 stock options to each of its directors at the time, Donald MacPhee, Scott Chapman, Mark Holcombe; 150,000 stock options to its controller, Peter Salvo; and 350,000 stock options to each of its special advisors, Robert Campbell and Karen Arsenault. The stock options expire on May 5, 2019. On November 30, 2015, Michael Browne’s stock options were amended to 625,000. On May 1, 2016, 100,000 stock options were granted to Steve Bromley, a Special Advisor to the Company and Chair of our Advisory Committee, with 50,000 of the options exercisable at a price of $1.25 per share, vesting May 1, 2017 and the remaining 50,000 options exercisable at a price of $1.50 per share, vesting May 1, 2018. All 100,000 options expire on May 1, 2021. On June 1, 2016 the Company issued to Mr. Bromley an additional 200,000 stock options under the 2013 Stock Option Plan, with 100,000 of the options exercisable at a price of $1.25 per share, vesting June 1, 2017 and the remaining 100,000 options exercisable at a price of $1.50 per share, vesting June 1, 2018. All 200,000 options were to expire on June 1, 2021. On November 1, 2016 an amended service contract with Steve Bromley was completed and the 200,000 stock options issued on June 1, 2016 were withdrawn. The original 100,000 stock options granted on May 1, 2016 remain in place. On September 30, 2016 Karen Arseneault resigned as a special advisor to the company. As a result, the unvested 116,667 options were immediately terminated and the remaining 233,333 options will expire on December 31, 2016 unless exercised. The total outstanding stock options as of November 30, 2016 are 2,358,333. The Company used the Black-Scholes model to value the stock options at $646,703. In 2016, the Company expensed $111,993 as compensation expense compared to $482,653 in the previous year. Following are the assumptions used for the shares vested 12, 24 and 36 months from the date of issuance: Discount rate .9%, 1.29%, 1.29%; Volatility 68.35%, 67.35%, 65.50%; and Term 3.0, 3.5, 4.0. The following table represents stock option activity as of and for the periods ended November 30, 2016 and 2015: Number of Options Weighted Average Exercise Price Contractual Life in Years Intrinsic Value Outstanding – November 30, 2014 2,875,000 $ 1.00 4.5 Exercisable – November 30, 2014 -0- Granted 250,000 $ .89 3.43 Exercised or Vested -0- Cancelled or Expired 750,000 Outstanding - November 30, 2015 2,375,000 $ 1.15 3.5 Exercisable - November 30, 2015 983,334 $ 2.00 3.4 Granted 300,000 $ 0.73 5.0 Exercised or Vested -0- Cancelled or Expired 316,667 Outstanding - November 30, 2016 2,358,333 $ 0.96 2.51 Exercisable - November 30, 2016 1,666,667 $ 1.17 2.43 $57,500 On January 29, 2016, the Company issued 125,000 warrants to purchase common shares of the Company along with the $250,000 secured third party promissory note. The relative fair value of the warrants is $43,526 which is recognized as debt discount. As of November 30, 2016, the promissory note was paid and the full $43,526 of the debt discount is amortized and the unamortized discount is $0. On March 4, 2016, the Company issued 100,000 warrants to purchase common shares of the Company along with the $200,000 secured related party promissory note. The relative fair value of the warrants is $35,250 which is recognized as debt discount. As of November 30, 2016, $26,438 of the debt discount is amortized and the unamortized discount is $8,812. The exercise price of both warrants is $1.35 with a term of 3 years and these are vested immediately. The Company uses the Black-Scholes model to value the warrants. Following are the assumptions used: Discount rate .9%; Volatility 76.25% and 77.30% respectively. The following table represents warrant activity for the periods ended November 30, 2016 and 2015: Number of Warrants Weighted Average Exercise Price Contractual Life in Years Intrinsic Value Outstanding – November 30, 2014 -0- Exercisable – November 30, 2014 -0- Granted -0- Exercised or Vested -0- Cancelled or Expired -0- Outstanding – November 30, 2015 -0- Exercisable - November 30, 2015 -0- Granted 225,000 $ 1.35 3.00 Exercised or Vested -0- Cancelled or Expired -0- Outstanding – November 30, 2016 225,000 $ 1.35 2.21

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Nov. 30, 2016
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS The Company neither owns nor leases any real or personal property. The Company is paying a director $750 per month rent for use of office space and services. During the quarter ended November 30, 2015, Continental Ingredients Canada, Inc. (“CIC”) of which the Company’s previous CEO owned a significant interest, loaned the Company $180,000 bearing interest at the rate of 8% per annum, payable on maturity, calculated on the principal amount of the loan outstanding. The $180,000 note was advanced during the year ended November 30, 2015. The full amount of the loan and accrued interest of $13,177 was repaid on September 27, 2016. On February 29, 2016, the Company entered into a Securities Purchase Agreement with CIC whereby the Company received proceeds of $200,000 on March 4, 2016 in return for a $200,000 secured promissory note due 12 months from the issuance date, bearing interest at the rate of 10% per annum, plus 100,000 warrants to purchase common shares of the Company at an exercise price of $1.35 per share for three years from the date of issue. As of November 30, 2016, the full amount of the loan is outstanding. See note 4 for valuation of warrants. During the year, the company purchased inventory from Continental Ingredients Canada, Inc. The total amount of inventory purchased in 2016 was $316,086 compared to $291,385 the previous year. On September 1, 2016 CIC was sold to an unrelated third party and as a result the Company’s previous CEO no longer owns a significant interest.

LOAN PAYABLE - THIRD PARTY

LOAN PAYABLE - THIRD PARTY	12 Months Ended
	Nov. 30, 2016
Debt Disclosure [Abstract]
LOAN PAYABLE - THIRD PARTY	NOTE 6. LOAN PAYABLE – THIRD PARTY During 2016 the Company had three short term loans, one for $200,000, one for $100,000 and the other for $250,000 bearing interest at the rate of 8.0%, 8.0% and 10.0% per annum respectively, payable on maturity, calculated on the principle amount of the loan outstanding. The loans for $200,000 and $250,000 were repaid on September 29, 2016 and the loan for $100,000 was repaid on October 4, 2016.

CONVERTIBLE NOTE

CONVERTIBLE NOTE	12 Months Ended
	Nov. 30, 2016
Convertible Note [Abstract]
CONVERTIBLE NOTE	NOTE 7. CONVERTIBLE NOTE On January 29, 2015, the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2,300,000 of senior secured convertible debentures, convertible into shares of the company’s common stock. The Company received $1,800,000 of the funds from the transaction on February 5, 2015. The balance of $500,000 was received on May 14, 2015. The convertible debentures are convertible into shares of the Company’s common stock at an initial conversion price of $.71 per share, for an aggregate of up to 3,239,437 shares. The debentures originally accrued interest at 6% per annum. On September 26, 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer, sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30, 2019. Due to the note being convertible to common shares of the Company, a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647,888 which was recognized as debt discount. As of November 30, 2016, the full amount of the debt discount has been amortized. On September 26, 2016, the Company entered into a securities purchase agreement with a non-US institutional investor, pursuant to which, in consideration for proceeds of $4,100,000, the Company issued a secured convertible promissory note in the amount of $4,100,000. Pursuant to the securities purchase agreement, the investor has agreed, from time to time after January 1, 2017, to make additional investments at the Company’s request of up to $5,900,000 ($10,000,000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4,100,000 which has been funded) is subject to the mutual agreement of the parties as to the use of funds. The parties have agreed to negotiate in good faith to pre-approve use of funds with 120 days following September 26, 2016. The Company intends to use the proceeds of the secured convertible note for general working capital purposes including, without limitation, settlement of accounts payable and repayment of mature loans. In consideration of each advance made by the investor pursuant to the securities purchase agreement, the Company will issue to the investor a convertible promissory note of equal value, maturing three years after issuance, and bearing interest at the rate of 8% per annum. Each note will be secured in first priority against the present and after acquired assets of the Company, and will be convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price of $.60 per share. Due to the note being convertible to common shares of the Company, a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $1,366,667 which was recognized as debt discount. As of November 30, 2016, $80,831 of debt discount was amortized and the unamortized discount is $1,285,836. The Company analyzed the embedded conversion option for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option should be classified as equity.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Nov. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 8. INTANGIBLE ASSETS On January 22, 2015, pursuant to a Deed of Assignment dated effective January 20, 2015, the Company entered into an Emulsion Supply Agreement with Oceans Omega LLC which represents the rights acquired pursuant to the Deed of Assignment. The Emulsion Supply Agreement provides the Company with the non-exclusive right and license (without the right to sublicense) to purchase, market, promote, sell and distribute Oceans Omega LLC’s omega-3 emulsions for use in the development, production, processing, manufacture and sale of food and beverages and exclusive rights to purchase, market, promote, sell and distribute Oceans Omega emulsions for meats, for human or animal consumption. On January 6, 2016 the Company issued 3,000,000 shares to mark the closing of the Deed of Assignment and the Emulsion Supply Agreement, which did not specify the amount of consideration payable by the Company when they were executed on January 20, 2015. The consideration payable was subsequently established by the parties at a market value of $2,700,000 and common shares issued as compensation based on the closing price of the common shares as quoted on the OTC Markets quotation systems on January 6, 2016. The value of the license is being amortized over the remaining contractual life which is 9 years. As of November 30, 2016, the net value of the license was $2,425,000 after amortizing $275,000.

EVERLAST LICENCE AGREEMENT

EVERLAST LICENCE AGREEMENT	12 Months Ended
	Nov. 30, 2016
Everlast Licence Agreement [Abstract]
EVERLAST LICENCE AGREEMENT	NOTE 9. EVERLAST LICENCE AGREEMENT On December 23, 2013, the Company entered into a Deed of Assignment Agreement with Everlast World’s Boxing Headquarters Corporation, International Brand Management Limited, Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast, International Brand, Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition, a New York corporation, has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement, Sports Nutrition Products Incorporated, a wholly owned subsidiary of Trident Brands Incorporated, assigned all of its rights, title, interest and benefit to the trade mark license to the Company effective December 23, 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary, Sports Nutrition Products Inc. The Everlast Licence Agreement includes a clause stating that Manchester Capital Incorporated will guarantee that the Licensee shall perform all of its obligations and duties under the Licence Agreement. If the Licensee defaults in the payment when due of any amount it is obliged to pay to Licensor under the Licence Agreement, or arising from its termination, Manchester Capital is unconditionally responsible to pay that amount to Licensor in the manner prescribed in the Licence Agreement as if it were the Licensee. The Royalty Calculation, as per the terms of the agreement, are as follows: In 2013, 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014, 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015, 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards, 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed Royalty is $120,000 in 2014, $235,000 in 2015, $320,000 in 2016, $345,000 in 2017 and in 2018 onwards, if the Agreement remains in force, will be 75% of the previous Year's Royalty Calculation or the previous Year's Annual Minimum Guaranteed Royalty plus 10%, whichever is greater.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Nov. 30, 2016
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 10. INCOME TAXES As of November 30, 2016 As of November 30, 2015 Deferred tax assets: Net operating tax carryforwards $ 5,313,340 $ 2,825,245 Tax Rate 35 % 35 % Gross deferred tax assets 1,859,669 988,836 Valuation allowance (1,859,669 ) (988,836 ) Net deferred tax assets $ -0- $ -0- As of November 30, 2016, the Company has a net operating loss carryforward of approximately $5.3 million. Net operating loss carryforwards expires twenty years from the date the loss was incurred. Realization of deferred tax assets is dependent upon sufficient future taxable income during the period that deductible temporary differences and carryforwards are expected to be available to reduce taxable income. As the achievement of required future taxable income is uncertain, the Company has recorded a valuation allowance.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Nov. 30, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS On February 15, 2017, Trident Brands Incorporated entered into a Letter of Intent (the “LOI”) with The Activation Group, Inc., an integrated marketing and advertising agency incorporated in Ontario, Canada. Pursuant to the LOI, Trident will seek to enter into a definitive agreement to purchase all the issued and outstanding common shares of The Activation Group in consideration for a purchase price consisting of $200,000 cash, and $800,000 payable in common shares of Trident. The cash consideration is inclusive of a $50,000 deposit paid to The Activation Group upon execution of the LOI, and $150,000 payable upon closing a definitive agreement. Stock payments shall be payable in four $200,000 installments, subject to the achievement of earnings targets. The transaction contemplated by the LOI will be subject to the satisfactory completion of due diligence by the Company, and to the negotiation and completion of a definitive agreement among the parties and the shareholders of The Activation Group. Also, on February 15, 2017 our board of directors appointed Mark Cluett as the Chief Operating Officer at Trident Brands Incorporated, with responsibility for business strategy execution and commercialization.

SUMMARY OF SIGNIFICANT ACCOUN18

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Nov. 30, 2016
Accounting Policies [Abstract]
Basis of Accounting	Basis of Accounting The Company’s financial statements are prepared using the accrual method of accounting. The Company has elected a November 30, year-end.
Use of Estimates and Assumptions	Use of Estimates and Assumptions The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. In accordance with ASC No. 250 all adjustments are normal and recurring.
Principal of Consolidation	Principal of Consolidation The Company consolidated financial statements as of November 30, 2016 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd, Sports Nutrition Products Inc., Brain Armor Inc. and Trident Brands International Ltd.
Basic Earnings (loss) Per Share	Basic Earnings (loss) Per Share ASC No. 260, “Earnings Per Share”, specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. The Company has adopted the provisions of ASC No. 260. Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company.
Cash Equivalents	Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary. Management has determined that a reserve for uncollectible amounts was not required in the periods presented.
Inventory	Inventory Inventories are stated at the lower of cost or market. Cost is principally determined using the first-in, first-out (FIFO) method.
Long-Lived Assets	Long-Lived Assets We review our long-lived assets, to include intangible assets subject to amortization, for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as "the asset") may not be recoverable. Such circumstances include, but are not limited to: · a significant decrease in the market price of the asset; · a significant change in the extent or manner in which the asset is being used; · a significant change in the business climate that could affect the value of the asset; · a current period loss combined with projection of continuing loss associated with use of the asset; and · a current expectation that, more likely than not, the asset will be sold or otherwise disposed of before the end of its previously estimated useful life. We continually evaluate whether such events and circumstances have occurred. When such events or circumstances exist, the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset. To date, no such impairment has occurred. To the extent such events or circumstances occur that could affect the recoverability of our long-lived assets, we may incur charges for impairment in the future.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company evaluates, on a periodic basis, long-lived assets to be held and used for impairment in accordance with the reporting requirements of ASC 360-10. The evaluation is based on certain impairment indicators, such as the nature of the assets, the future economic benefit of the assets, any historical or future profitability measurements, as well as other external market conditions or factors that may be present. If these impairment indicators are present or other factors exist that indicate that the carrying amount of the asset may not be recoverable, then an estimate of the undiscounted value of expected future operating cash flows is used to determine whether the asset is recoverable and the amount of any impairment is measured as the difference between the carrying amount of the asset and its estimated fair value. The fair value is estimated using valuation techniques such as market prices for similar assets or discounted future operating cash flows.
Beneficial Conversion Features	Beneficial Conversion Features The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars. Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
Revenue	Revenue The Company maintains a portfolio of branded and private label consumer products including nutritional products and supplements under the Everlast® and Brain Armor® brands, and functional food ingredients under the Oceans Omega brand. Revenue for 2016 was $168,042. Two customers accounted for 48.9% and 27.2% of total revenue. With the delisting of one of our products, we adjusted fourth quarter revenues downward by $94,308 based on a calculation of the estimated product to be returned by one of our customers in the second quarter of 2017. The Company records revenue based on the following four criteria: collection probability is reasonably assured, product is shipped or delivery is complete (depending on the terms), persuasive evidence of an arrangement with the customer exists and the price to the customer can be determined.
Cost of Sales	Cost of Sales Cost of sales includes the direct purchase cost of the product based on the FIFO method. Cost of sales for 2016 was $97,738. Cost of sales was adjusted downward by $49,040 in the fourth quarter for the estimated product to be returned as noted above under Revenue.
Employee Stock-Based Compensation	Employee Stock-Based Compensation The company accounts for employee stock-based compensation in accordance with ASC-718, “Compensation-Stock Compensation”. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.
Non-Employee Stock-Based Compensation	Non-Employee Stock-Based Compensation: The Company accounts for non-employee stock-based compensation in accordance with the provision of ASC 505-50, “Equity Based Payments to Non-Employees” (“ASC 505-50”), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.
Income Taxes	Income Taxes Income taxes are provided in accordance with ASC No. 740, Accounting for Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion of all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Related Parties	Related Parties A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.
Recent Accounting Pronoucements	Recent Accounting Pronouncements The Company has evaluated all the recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that none of them will have a material effect on the Company’s financial statements

WARRANTS AND OPTIONS (Tables)

WARRANTS AND OPTIONS (Tables)	12 Months Ended
	Nov. 30, 2016
Warrants And Options [Abstract]
Schedule of stock option activity	Number of Options Weighted Average Exercise Price Contractual Life in Years Intrinsic Value Outstanding – November 30, 2014 2,875,000 $ 1.00 4.5 Exercisable – November 30, 2014 -0- Granted 250,000 $ .89 3.43 Exercised or Vested -0- Cancelled or Expired 750,000 Outstanding - November 30, 2015 2,375,000 $ 1.15 3.5 Exercisable - November 30, 2015 983,334 $ 2.00 3.4 Granted 300,000 $ 0.73 5.0 Exercised or Vested -0- Cancelled or Expired 316,667 Outstanding - November 30, 2016 2,358,333 $ 0.96 2.51 Exercisable - November 30, 2016 1,666,667 $ 1.17 2.43 $57,500
Schedule of warrant activity	Number of Warrants Weighted Average Exercise Price Contractual Life in Years Intrinsic Value Outstanding – November 30, 2014 -0- Exercisable – November 30, 2014 -0- Granted -0- Exercised or Vested -0- Cancelled or Expired -0- Outstanding – November 30, 2015 -0- Exercisable - November 30, 2015 -0- Granted 225,000 $ 1.35 3.00 Exercised or Vested -0- Cancelled or Expired -0- Outstanding – November 30, 2016 225,000 $ 1.35 2.21

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Nov. 30, 2016
Income Tax Disclosure [Abstract]
Schedule of net deferred tax assets	As of November 30, 2016 As of November 30, 2015 Deferred tax assets: Net operating tax carryforwards $ 5,313,340 $ 2,825,245 Tax Rate 35 % 35 % Gross deferred tax assets 1,859,669 988,836 Valuation allowance (1,859,669 ) (988,836 ) Net deferred tax assets $ -0- $ -0-

SUMMARY OF SIGNIFICANT ACCOUN21

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Concentration Risk [Line Items]
Revenues	$ 168,042	$ 16,569
Cost of Sales	97,738	$ 9,951
Cost of sales adjusted	49,040
Adjusted revenue	$ 94,308
Revenue | Customer one
Concentration Risk [Line Items]
Percentage of total revenue	48.90%
Revenue | Customer two
Concentration Risk [Line Items]
Percentage of total revenue	27.20%

LIQUIDITY (Detail textuals)

LIQUIDITY (Detail textuals) - USD ($)	1 Months Ended	12 Months Ended
	Sep. 26, 2016	Nov. 30, 2016	Nov. 30, 2015
Liquidity [Line Items]
Proceeds from promissory note		$ 200,000	$ 255,000
Secured convertible promissory note | Securities purchase agreement
Liquidity [Line Items]
Proceeds from promissory note	$ 4,100,000
Additional funding amount	5,900,000
Aggregate amount of promissory note	$ 10,000,000
Available cash from investors		1,527,624
Available financing from investor		$ 5,900,000

WARRANTS AND OPTIONS (Details)

WARRANTS AND OPTIONS (Details) - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015	Nov. 30, 2014
Number of Options
Outstanding	2,375,000	2,875,000
Exercisable	983,334	0
Granted	300,000	250,000
Exercised or Vested	0	0
Cancelled or Expired	316,667	750,000
Outstanding	2,358,333	2,375,000	2,875,000
Exercisable	1,666,667	983,334	0
Weighted Average Exercise Price
Outstanding	$ 1.15	$ 1
Exercisable	2
Granted	0.73	0.89
Outstanding	0.96	1.15	$ 1
Exercisable	$ 1.17	$ 2
Outstanding Contractual Life in Years	2 years 6 months 4 days	3 years 6 months	4 years 6 months
Granted	6 years	3 years 5 months 5 days
Exercisable Contractual Life in Years	2 years 5 months 5 days	3 years 4 months 24 days
Exercisable Intrinsic Value	$ 57,500

WARRANTS AND OPTIONS (Details 1

WARRANTS AND OPTIONS (Details 1) - $ / shares	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Number Of Warrants [Roll Forward]
Outstanding - November 30, 2015	0	0
Exercisable - November 30, 2015	0	0
Granted	225,000	0
Exercised or Vested	0	0
Cancelled or Expired	0	0
Outstanding - November 30, 2016	225,000	0
Class Of Warrant Or Right Additional Information [Abstract]
Granted	$ 1.35
Exercised or Vested	$ 1.35
Granted contractual life in years	3 years
Outstanding contractual life	2 years 2 months 16 days

WARRANTS AND OPTIONS (Detail te

WARRANTS AND OPTIONS (Detail textuals) - USD ($)	Mar. 04, 2016	May 05, 2014	Jun. 01, 2016	May 01, 2016	Jan. 29, 2016	Nov. 30, 2016	Nov. 30, 2015	Nov. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total outstanding stock options						2,358,333	2,375,000	2,875,000
Value of stock option using Black-Scholes model						$ 646,703
Number of stock options granted						300,000	250,000
Number of stock options excercisable						1,666,667	983,334	0
Exercise price (in dollars per share)						$ 0.73	$ 0.89
Share-based Compensation						$ 111,994	$ 482,653
Amortization of debt discount						298,025	$ 500,657
Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in dollars per share)	$ 1.35				$ 1.35
Relative fair value of warrants recognized as debt discount					$ 43,526
Number of shares called by warrants	100,000				125,000
Fair value assumption model used	Black-Scholes model				Black-Scholes model
Discount rate	0.90%				0.90%
Volatility	77.30%				76.25%
Term	3 years				3 years
Secured third party promissory note
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Principal amount of debt					$ 250,000
Amortization of debt discount						43,526
Unamortized debt discount						0
Secured related party promissory note
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation	$ 200,000
Principal amount of debt	$ 35,250
Amortization of debt discount						26,438
Unamortized debt discount						$ 8,812
Shares vesting 12 months
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumption model used						Black-Scholes model
Discount rate						0.90%
Volatility						68.35%
Term						3 years
Shares vesting 24 months
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumption model used						Black-Scholes model
Discount rate						1.29%
Volatility						67.35%
Term						3 years 6 months
Shares vesting 36 months
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumption model used						Black-Scholes model
Discount rate						1.29%
Volatility						65.50%
Term						4 years
Trident's 2013 Stock Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted		2,875,000				2,375,000
Stock options exercise period		5 years
Trident's 2013 Stock Plan | Stock options | Michael Brown
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted		1,125,000					625,000
Trident's 2013 Stock Plan | Stock options | Donald Macphee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted		300,000
Trident's 2013 Stock Plan | Stock options | Scott Chapman
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted		300,000
Trident's 2013 Stock Plan | Stock options | Mark Holcombe
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted		300,000
Trident's 2013 Stock Plan | Stock options | Peter Salvo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted		150,000
Trident's 2013 Stock Plan | Stock options | Robert Campbell
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted		350,000
Trident's 2013 Stock Plan | Stock options | Karen Arsenault
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of unvested stock option terminated						116,667
Number of unvested stock option expired						233,333
Number of stock options granted		350,000
Trident's 2013 Stock Plan | Stock options | Steve Bromley
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted			200,000	100,000
Stock option expiration period			Jun. 1, 2021	May 1, 2021
Trident's 2013 Stock Plan | Stock options | Shares vesting 12 months
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in dollars per share)		$ 0.75
Vesting period		12 months
Trident's 2013 Stock Plan | Stock options | Shares vesting 12 months | Steve Bromley
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options excercisable			100,000	50,000
Exercise price (in dollars per share)			$ 1.25	$ 1.25
Trident's 2013 Stock Plan | Stock options | Shares vesting 24 months
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in dollars per share)		$ 1
Vesting period		24 months
Trident's 2013 Stock Plan | Stock options | Shares vesting 24 months | Steve Bromley
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options excercisable			100,000	50,000
Exercise price (in dollars per share)			$ 1.50	$ 1.50
Trident's 2013 Stock Plan | Stock options | Shares vesting 36 months
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in dollars per share)		$ 1.50
Vesting period		36 months

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Detail Textuals) - USD ($)	Mar. 04, 2016	Sep. 26, 2016	Feb. 29, 2016	Nov. 30, 2016	Nov. 30, 2015
Related Party Transaction [Line Items]
Weighted average exercise price				$ 1.35
Proceeds from notes payable				$ 200,000	$ 255,000
Loan Payable - Related Party, net of discount $8,812 and $0, respectively				191,188	$ 180,000
Securities purchase agreement | Secured convertible promissory note
Related Party Transaction [Line Items]
Proceeds from notes payable		$ 4,100,000
Continental Ingredients Canada, Inc.
Related Party Transaction [Line Items]
Interest rate					8.00%
Loan Payable - Related Party, net of discount $8,812 and $0, respectively					$ 180,000
Amount of inventory purchased				$ 316,086	291,385
Accrued interest expense repaid on September 27, 2016					13,177
Continental Ingredients Canada, Inc. | Securities purchase agreement | Secured convertible promissory note
Related Party Transaction [Line Items]
Interest rate	10.00%
Secured promissory note	$ 200,000
Number of shares called by warrants	100,000
Weighted average exercise price	$ 1.35
Warrant term	3 years
Proceeds from notes payable			$ 200,000
Director
Related Party Transaction [Line Items]
Rent paid per month					$ 750

LOAN PAYABLE - THIRD PARTY (Det

LOAN PAYABLE - THIRD PARTY (Detail Textuals)	Oct. 04, 2016USD ($)	Sep. 29, 2016USD ($)	Nov. 30, 2016USD ($)Unrelated_shareholder	Nov. 30, 2015USD ($)
Short-term Debt [Line Items]
Short term loan			$ 250,000	$ 100,000
Number of promissory notes issued | Unrelated_shareholder			3
Short Term Loan One
Short-term Debt [Line Items]
Short term loan			$ 200,000
Loan interest rate			8.00%
Repayment of promissory note		$ 200,000
Short Term Loan Two
Short-term Debt [Line Items]
Short term loan			$ 100,000
Loan interest rate			8.00%
Repayment of promissory note	$ 100,000
Short Term Loan Three
Short-term Debt [Line Items]
Short term loan			$ 250,000
Loan interest rate			10.00%
Repayment of promissory note		$ 250,000

CONVERTIBLE NOTE (Detail Textua

CONVERTIBLE NOTE (Detail Textuals) - USD ($)	May 14, 2015	Feb. 05, 2015	Sep. 26, 2016	Jan. 29, 2015	Nov. 30, 2016	Nov. 30, 2015
Debt Instrument [Line Items]
Funds received					$ 4,100,000	$ 2,300,000
Amount of intrinsic value recognized as debt discount					1,366,667	647,887
Amortization of debt discount					298,025	500,657
Unamortized debt discount					1,285,836
Proceeds from promissory note					200,000	$ 255,000
Securities purchase agreement | Senior secured convertible debentures
Debt Instrument [Line Items]
Principal amount of debt			$ 4,100,000	$ 2,300,000
Funds received	$ 500,000	$ 1,800,000
Common stock conversion, shares				3,239,437
Percentage of interest rate			8.00%	6.00%
Accrued interest expense				$ 104,442
Amount of intrinsic value recognized as debt discount			$ 1,366,667	$ 647,888
Amortization of debt discount					80,831
Unamortized debt discount					$ 1,285,836
Maturity date of notes			Sep. 30, 2019
Proceeds from promissory note			$ 4,100,000
Additional funding amount			5,900,000
Aggregate amount of promissory note			$ 10,000,000
Promissory note maturity period			3 years
Conversion price			$ 0.60	$ 0.71

INTANGIBLE ASSETS (Detail Textu

INTANGIBLE ASSETS (Detail Textuals) - USD ($)	Jan. 06, 2016	Nov. 30, 2016
Finite-Lived Intangible Assets [Line Items]
Useful life of intangible asset		9 years
Net value of the license		$ 2,425,000
Accumulated amortization of license		$ 275,000
Licensing Agreements | Emulsion Supply Agreement | Oceans Omega LLC
Finite-Lived Intangible Assets [Line Items]
Shares issued to mark closing of agreement	3,000,000
Market value of consideration payable	$ 2,700,000

EVERLAST LICENCE AGREEMENT (Det

EVERLAST LICENCE AGREEMENT (Detail Textuals) - Deed of Assignment Agreement - Everlast World's Boxing Headquarters Corporation - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015	Nov. 30, 2014	Nov. 30, 2013
Everlast Licence Agreement [Line Items]
Net Retail Sales, percentage	10.00%	9.00%	8.00%	7.00%
Direct Response Sales Revenue, percentage	60.00%	60.00%	60.00%	60.00%
Direct Response Sales Revenue, percentage description	10% of 60% of Direct Response Sales Revenue	9% of 60% of Direct Response Sales Revenue	8% of 60% of Direct Response Sales Revenue	7% of 60% of Direct Response Sales Revenue
Net Retail Sales. percentage in 2016 onwards	10.00%
Direct Response Sales Revenue, percentage in 2016 onwards	60.00%
Direct Response Sales Revenue, percentage description in 2016 onwards	10% of 60% of Direct Response Sales Revenue
Annual Minimum Guaranteed Royalty	$ 320,000	$ 235,000	$ 120,000
Annual Minimum Guaranteed Royalty in 2017	345,000
Annual Minimum Guaranteed Royalty in 2018 onwards	$ 345,000
Royalty Calculation terms of agreement	The Royalty Calculation, as per the terms of the agreement, are as follows: In 2013, 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014, 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015, 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards, 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed Royalty is $120,000 in 2014, $235,000 in 2015, $320,000 in 2016, $345,000 in 2017 and in 2018 onwards, if the Agreement remains in force, will be 75% of the previous Year's Royalty Calculation or the previous Year's Annual Minimum Guaranteed Royalty plus 10%, whichever is greater.

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Deferred tax assets:
Net operating tax carryforwards	$ 5,313,340	$ 2,825,245
Tax rate	35.00%	35.00%
Gross deferred tax assets	$ 1,859,669	$ 988,836
Valuation allowance	(1,859,669)	(988,836)
Net deferred tax assets	$ 0	$ 0

INCOME TAXES (Detail Textuals)

INCOME TAXES (Detail Textuals) - USD ($)	Nov. 30, 2016	Nov. 30, 2015
Income Tax Disclosure [Abstract]
Net operating tax carryforwards	$ 5,313,340	$ 2,825,245

SUBSEQUENT EVENTS (Detail Textu

SUBSEQUENT EVENTS (Detail Textuals) - Subsequent event - Activation Group, Inc	1 Months Ended
	Feb. 15, 2017USD ($)Installment
Subsequent Event [Line Items]
Purchase price in cash	$ 200,000
Purchase price payable in common shares	$ 800,000
Description of stock payments	Stock payments shall be payable in four $200,000 installments, subject to the achievement of earnings targets.
Number of installment for stock payment | Installment	4
Stock payment made in four installments	$ 200,000
Deposit
Subsequent Event [Line Items]
Purchase price in cash	50,000
Definitive agreement
Subsequent Event [Line Items]
Purchase price in cash	$ 150,000